Diadem

company

About

Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.

  • 1 - 10

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€7.50M
Industries
Therapeutics
Founded date
Jun 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€7.50M
Diadem has raised a total of €7.50M in funding over 2 rounds. Their latest funding was raised on Mar 7, 2022 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 7, 2022 Debt Financing €7.50M 1 European Investment Bank Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Diadem is funded by 1 investors. European Investment Bank are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing